Drug Database
CA

calcifediol (Replidea / JTT 762 / CTAP 101)

✓ Approved

Pharmsynthez · VDR · 小分子

什么是 calcifediol?

calcifediol 是一种小分子,由Pharmsynthez研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)、Oral (PO)。

药物档案

商品名Replidea, JTT 762, CTAP 101
公司Pharmsynthez
药物类别小分子
分子靶点VDR
给药途径Injectable (Others), Intravenous (IV), Oral (PO)
状态Approved

作用机制

分子靶点

calcifediol 作用于 1 个分子靶点:

VDRvitamin D receptor (NR1I1, PPP1R163)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

calcifediol 针对 5 个适应症,涉及 5 个治疗领域。

治疗领域疾病/病症分期
Endocrine disordersHyperparathyroidism secondary✓ Approved
Metabolism and nutrition disordersVitamin D deficiency✓ Approved
Renal and urinary disordersEnd stage renal disease✓ Approved
Infections and infestationsCOVID-19Phase II
Immune system disordersCytokine release syndromePreclinical

相关研究文献

PubMedGels (Basel, Switzerland)2026-10-26

Optimization of Hydrophobic Group Structures Covalently Incorporated into Gelatin Hydrogels for Efficient Adsorption and Release of Hydrophobic Drugs.

Nishimura Ko K, Matsumoto Takanori T, Kanamaru Kazunori K, Kobaru Saki S et al.

Hydrophobically modified gelatin (HMG) hydrogels are promising proof-of-concept drug delivery carriers. However, the structural effects of incorporated hydrophobic groups remain systematically unexamined. Here, twelve linear fatty and aromatic hydrophobic groups with varying carbon numbers were incorporated into gelatin to identify optimal structures for hydrophobic drug loading. Adsorption behaviors of three drug models were quantitatively evaluated per mole of incorporated carbon atoms. Linear fatty aldehydes with 11 and 12 carbon atoms (F-CHO-C11 and C12) achieved maximum adsorption efficiency, with equilibrium adsorption capacities of 0.35×10-3 and 0.34×10-3 mol-rhodamine B/mol-carbon atoms, respectively. Thermodynamic calculations (COSMO-SAC) and quantum chemical simulations (Gaussian MP2) supported the idea that longer alkyl chains enhance affinity, yielding higher interaction energy (-11.8kcal/mol for C12 vs. -5.73kcal/mol for C4). Furthermore, F-CHO-C12 HMG hydrogel achieved a substantial dexamethasone loading capacity of approximately 2.8×10-6 mol/g-dry polymer (unmodified gelatin showed negligible loading <0.08×10-6 mol/g-dry polymer) and sustained release at 37 °C (∼95% cumulative release without initial burst). These findings establish quantitative design guidelines for hydrophobically modified polymer hydrogels.

PMID 42929975
阅读全文 →
PubMedGels (Basel, Switzerland)2026-10-26

Cyclodextrin-Containing Tannic Acid-Lipoic Acid Hydrogels for the Loading and Reduction-Responsive Release of Nile Red.

Zhu Yuzheng Y, Kobayashi Kazuya U KU, Hatano Akihiko A, Suzuki Manabu M et al.

Hydrophobic molecules are generally difficult to incorporate into aqueous hydrogels because of their poor water solubility. In this study, a cyclodextrin (CD)-containing tannic acid-lipoic acid (TA-LA) hydrogel was developed using lipoic acid-modified β-cyclodextrin (LACD). LACD retained the host-guest recognition ability of the cyclodextrin cavity after lipoic acid modification and was successfully incorporated into the TA-LA hydrogel without interfering with gel formation. Using Nile Red (NR) as a model hydrophobic molecule, the LACD-containing hydrogel showed higher NR encapsulation efficiency and greater cyclodextrin retention than the hydrogel containing unmodified β-cyclodextrin. The LACD-containing hydrogel also exhibited reduction-responsive NR release in the presence of dithiothreitol (DTT). These results show that LACD can be incorporated into the TA-LA hydrogel while retaining the host-guest recognition ability of the cyclodextrin cavity and can be used for reduction-responsive release of NR.

PMID 42929903
阅读全文 →
PubMedGels (Basel, Switzerland)2026-10-26

Copper Peroxide-Loaded Dual-Responsive Hydrogel for Enhanced Diabetic Wound Healing Through Oxygen Release and Promotion of Angiogenesis.

Yu Lanqin L, Jia Xiang X, Xu Lejia L, Li Xiaojun X et al.

Diabetic foot ulcers (DFUs) present a major clinical challenge because of persistent hyperglycemia, hypoxia, impaired angiogenesis, and chronic inflammation. Conventional dressings have limited capacity to modulate these pathological processes. Here, we report a glucose/pH dual-responsive hydrogel, denoted CBOD, constructed through a dynamic covalent network comprising Schiff base and boronate ester bonds between phenylboronic acid-grafted chitosan (CS-BA) and dopamine-modified oxidized sodium alginate (OSA-DA). Copper peroxide (CuO2) nanoparticles are encapsulated within this network to form CuO2/CBOD. Under acidic (pH 5.5) and high-glucose conditions, competitive binding and bond hydrolysis promote network relaxation, facilitating the stimuli-dependent release of oxygen and copper ions. In vitro assessments demonstrate good cytocompatibility and enhanced migration and tube formation of human umbilical vein endothelial cells (HUVECs). In a diabetic rat model of full-thickness excisional wounds, the hydrogel accelerates wound closure, with closure approaching 100% by day 14. Treatment is associated with reduced expression of the M1-associated markers interleukin-1β (IL-1β) and cluster of differentiation 80 (CD80), increased expression of the M2-associated markers interleukin-10 (IL-10) and cluster of differentiation 163 (CD163), and enhanced expression of the vascular markers cluster of differentiation 31 (CD31) and alpha-smooth muscle actin (α-SMA). These findings support the potential of CuO2/CBOD as a multifunctional dressing for diabetic wound management.

PMID 42929899
阅读全文 →
PubMedChembiochem : a European journal of chemical biology2026-10-26

Vitamin B12-Functionalized Nanogels for pH-, and Redox-Responsive Doxorubicin Delivery.

Dagdelen Serife S, Mestizo Paula D PD, Mackiewicz Marcin M, Kurdyn Agnieszka A et al.

Rapidly proliferating cancer cells display an elevated demand for vitamin B12, rendering this bacterial-derived cofactor an attractive targeting motif for nanotherapeutic drug delivery. Herein, we report a concise two-step synthesis of a polymerizable 5'-modified vitamin B12 -monomer that enables the covalent integration of B12 into pH- and redox-responsive nanogels. The resulting nanogels efficiently encapsulate doxorubicin through electrostatic interactions between the cationic drug and the anionic nanogel network, while enabling stimuli-responsive drug release under tumor-relevant conditions. In vitro studies revealed that DOX@B12-nanogels retain potent antiproliferative activity against HT-29 colorectal cancer cells (IC50 = 0.878 ± 0.102 μM), while decreasing cytotoxicity toward healthy CCD 841 CoN cells by 34-fold relative to non-B12-functionalized control nanogels. These findings establish covalently engineered vitamin B12-nanogels as a promising platform for selective and stimuli-responsive anticancer drug delivery.

PMID 42929280
阅读全文 →
PubMedGels (Basel, Switzerland)2026-10-26

Research Progress of Polyacrylamide Gels for Oilfield Applications: A Systematic Review.

Dong Ruiqiang R, Chen Guanyu G, Li Daoyong D, Cui Xinyue X et al.

In the middle-to-late stage of reservoir development, widespread high-permeability channeling exacerbates ineffective water circulation and impairs crude oil recovery. This work explores polyacrylamide (PAM) gels intended for oilfield profile control and water shut-off. It comprehensively compares gelation behaviors and performance metrics of diverse cross-linking and modification strategies, and pinpoints critical unresolved research gaps. Four representative PAM-gel systems are analyzed in detail, including organic-crosslinked, metal-crosslinked, nano-composite-modified, and delayed-crosslinker formulations. The results show that polyethyleneimine (PEI) cross-linked gels achieve a storage modulus of 780 kPa at 110 °C, which is superior to the conventional hydroquinone-hexamethylenetetramine (HQ-HMTA) system. Metal-crosslinked gels are prone to syneresis and structural instability above 70 °C. Nanocomposite modification significantly enhances gel comprehensive properties: nano-silica improves thermal resistance to 155.5 °C; modified nano-graphite doubles storage modulus (G'), shortens gelation time by half, and maintains 76.5% of initial modulus after 60-day aging at 130 °C; TOCN-reinforced gels preserve structural integrity under high-salinity environments at 140 °C for 108 h. Delayed-release cross-linkers can extend gelation time up to 17 days to meet the demands of deep in situ profile control. Furthermore, the emerging data-driven paradigm of artificial-intelligence-assisted gel optimization is also reviewed, together with its current limitations. Future research priorities cover intelligent responsive gel materials, environmentally benign cross-linkers, and unified evaluation specifications for heterogeneous reservoirs. This paper reviews over 100 core publications from 2000 to 2026 based on the Web of Science and Engineering Village databases. Different from existing studies, this work emphasizes the molecular crosslinker mechanisms, nanomodification reinforcement, and field performance variations of PAM gel systems, and concludes the major technical bottlenecks for their application in harsh reservoirs. Meanwhile, it quantitatively compares the performance of modified PAM gel formulations and clarifies the applicable temperature ranges of different crosslinker schemes, providing technical references for the development of PAM plugging agents for complex oil reservoirs.

PMID 42929937
阅读全文 →
PubMedGels (Basel, Switzerland)2026-10-26

Stimuli-Responsive Hydrogels for Oral Probiotic Delivery: Balancing Protection and Site-Specific Release.

Jung Sungwon S, Noh Sookyung S, Lee Hyeonseung H, Park Sohyeon S

Successful oral probiotic delivery requires protection of viable cells during gastrointestinal transit followed by efficient release at the target intestinal site. Stimuli-responsive hydrogels can provide both functions, although network properties that restrict acid, bile, and enzyme transport may also delay the structural changes required for release. This review discusses how crosslink density, particle geometry, the internal microenvironment, and interfacial layers shape this protection-release relationship. pH-, enzyme/microbiota-, redox-, and multi-stimuli-responsive systems are compared with emphasis on the structural changes that allow bacterial escape. Because probiotic cells are much larger than the molecular mesh of most hydrogels, release generally requires network opening through swelling, formation or enlargement of cell-scale pores or defects, erosion, fracture, de-crosslinking, or dissolution rather than ordinary molecular diffusion. Delivery performance should therefore be evaluated using release kinetics, viability of released cells, retained cells, and total viable recovery in sequential gastrointestinal models. Strain-specific testing, storage studies, and in vivo validation will also be important. The practical goal is a reproducible protection-release window that maintains cell viability without delaying release.

PMID 42929896
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多calcifediol